Figure 3: SARS-CoV-2 S1 reactive T cells and neutralisation capacity over time in the total group by age group and by comorbidity status
Figure 3: SARS-CoV-2 S1 reactive T cells and neutralisation capacity over time in the total group by age group and by comorbidity status